Nexalin Technology Inc. Company Profile
NASDAQ: NXLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Nexalin Technology at a glance
Nexalin Technology Inc. (NASDAQ: NXL) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company in the Health Care sector headquartered in Houston, TX. Nexalin Technology is led by Mr. Mark White and employs about 8 people. The company's shares have traded publicly since 2022.
At a market capitalization of $3.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001527352, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Nexalin Technology do?
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Business description based on the company's public filings.
Company information
- Legal name
- Nexalin Technology Inc.
- Ticker
- NASDAQ: NXL
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. Mark White
- Employees
- 8
- Headquarters
- 1776 Yorktown, Houston, TX, United States
- Phone
- 832 260 0222
- Website
- nexalin.com
- IPO year
- 2022
- Market cap
- $3.01M
- SEC CIK
- 0001527352
Companies similar to Nexalin Technology
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NUWENuwellis Inc. | 0.689 | +2.07% | $2.51M | vs NXL |
| VBIOValion Bio Inc. | 2.14 | -3.17% | $4.17M | vs NXL |
| NDRAENDRA Life Sciences Inc. | 5.46 | -7.93% | $8.19M | vs NXL |
| IRIXIRIDEX Corporation | 0.89 | -0.89% | $15.63M | vs NXL |
| ITOCiTonic Holdings Ltd Class A | 4.07 | +1.12% | $29.74M | vs NXL |
| QTIQT Imaging Holdings Inc. | 2.68 | +3.08% | $39.23M | vs NXL |
| POCIPrecision Optics Corporation Inc. | 4.58 | -1.82% | $50.26M | vs NXL |
| OMOutset Medical Inc. | 4.05 | -0.98% | $76.13M | vs NXL |